Tactile Systems Technology Inc宣布完成对Lymphatech公司的收购,此举将大幅拓展其在淋巴水肿治疗领域的产品组合,并增强解决方案的深度与广度。通过此次战略收购,Tactile Medical进一步巩固了其在慢性疾病管理市场的领先地位。
Tactile Systems Technology Inc宣布完成对Lymphatech公司的收购,此举将大幅拓展其在淋巴水肿治疗领域的产品组合,并增强解决方案的深度与广度。通过此次战略收购,Tactile Medical进一步巩固了其在慢性疾病管理市场的领先地位。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.